HemaCare Co. (OTCMKTS:HEMA – Get Free Report)’s stock price traded up 0.6% during trading on Wednesday . The stock traded as high as $25.31 and last traded at $25.31. 5,400 shares changed hands during trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Up 0.6%
The business’s 50-day moving average is $25.31 and its two-hundred day moving average is $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Featured Stories
- Five stocks we like better than HemaCare
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Datavault AI: The New AI Contender Backed by Big Funding
- Insider Buying Explained: What Investors Need to Know
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- What Investors Need to Know About Upcoming IPOs
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
